Clinical trials: Painful Bladder Syndrome
Interstitial Cystitis, Painful Bladder Syndrome
Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome
A new device for interstitial cystitis is compared to inactive control to determine if it is safe and effective. The study lasts approximately 7 weeks with a 19-week follow-up period.
- Trial name
- NCT00919113
- Testing
- 2% sodium chondroitin sulfate
- Where
- 20 sites in United States
- Volunteers
- 98 people
- Sponsor
- Watson Pharmaceuticals
Interstitial Cystitis, Painful Bladder Syndrome
Bladder Thermal Distention for Patients With Interstitial Cystitis / Painful Bladder Syndrome
Patients with Interstitial Cystitis / PBS will be treated with bladder thermal distention (BTD).
- Trial name
- IC (NCT01838486)
- Testing
- Bladder Thermal Distention
- Where
- Israel
- Volunteers
- 20 people
- Sponsor
- Assaf-Harofeh Medical Center
Painful Bladder Syndrome, Interstitial Cystitis
Botox as a Treatment for Interstitial Cystitis in Women
Patients with interstitial cystitis have been well documented to have pelvic floor muscle tenderness as well as pain on bladder distension.
- Trial name
- NCT00194610
- Testing
- Botox, normal saline
- Volunteers
- 20 people
- Sponsor
- University of Washington
Painful Bladder Syndrome
Identifying Predictors of Treatment Success in Painful Bladder Syndrome
Study aims to: (1) evaluate the role of morphological and physiological characteristics of the pelvic floor, pain-related psychological and -psychophysical variables in prediction of the success of myofascial physical therapy…
- Trial name
- PBS (NCT01410461)
- Testing
- quantitive sensory testing, Ultrasound testing
- Where
- Israel
- Volunteers
- 35 people
- Sponsor
- Rambam Health Care Campus
Pelvic Pain, Abdominal Pain
Female Chronic Pelvic Pain
The purpose of this study is to investigate the frequency and severity of chronic pelvic pain (CPP) in adult women living in Copenhagen Country and Zealand Country (total population 2,4 million), Denmark, in relation to selected…
- Conditions
- Pelvic Pain, Abdominal Pain, Painful Bladder Syndrome, Interstitial Cystitis
- Trial name
- Female CPP (NCT01255345)
- Testing
- Chronic pelvic pain
- Where
- Denmark
- Volunteers
- 2,500 people, healthy volunteers welcome
- Sponsor
- Copenhagen University Hospital at Herlev
Painful Bladder Syndrome (PBS)
Botulinum A Toxin in the Treatment of Patients With Painful Bladder Syndrome
Previous clinical observations showed that Botulinum A toxin (BoNT/A) has also an antinociceptive effect and can control the neuropathic pain.
- Trial name
- NCT01157507
- Testing
- Intravesical injection of Botulinum A Toxin, Bladder overdistension
- Where
- Italy
- Volunteers
- 30 people
- Sponsor
- University Of Perugia
Interstitial Cystitis, Painful Bladder Syndrome
An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis
The purpose of this study is to determine whether PD 0299685 is effective in the treatment of symptoms associated with interstitial cystitis/painful bladder syndrome, such as pain, urinary urgency and frequency.
- Trial name
- NCT00739739
- Testing
- PD 0299685 at 15mg BID, PD 0299685 at 30mg BID
- Where
- 44 sites in United States, Canada and 4 more
- Volunteers
- 161 people
- Sponsor
- Pfizer
Interstitial Cystitis, Painful Bladder Syndrome
Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome
By hypothesising that Interstitial Cystitis is an allergic disorder of the urogenital system that is linked to mast-cells, current therapy with omalizumab may represent a potential non symptomatic strategy for the treatment of…
- Trial name
- IComaliz (NCT01294878)
- Testing
- omalizumab
- Where
- Italy
- Volunteers
- 3 people
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
Overactive Bladder, Painful Bladder Syndrome
Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.
Interstitial cystitis (IC)/chronic pelvic pain syndrome (CPPS) is a clinical syndrome of pelvic pain and/or urinary urgency/frequency in absence of a specific cause such as bacterial infection or damage to the bladder.
- Conditions
- Overactive Bladder, Painful Bladder Syndrome, Chronic Pelvic Pain Syndrome, Cystitis, Interstitial
- Trial name
- NCT00775281
- Where
- Switzerland
- Volunteers
- 45 people, healthy volunteers welcome
- Sponsor
- Insel Gruppe AG, University Hospital Bern
Interstitial Cystitis, Painful Bladder Syndrome
A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . .
The purpose of this study is to investigate the safety and effectiveness of a medication called CellCept in treating refractory (has not responded to other treatments) interstitial cystitis.
- Trial name
- ICCRN RCT2 (NCT00451867)
- Testing
- Mycophenolate Mofetil, Mycofenolate Mofetil (MMF)
- Where
- 11 sites in United States, Canada
- Volunteers
- 210 people
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)